期刊
MEDCHEMCOMM
卷 4, 期 1, 页码 80-87出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c2md20242e
关键词
-
资金
- Spanish Ministerio de Economia y Competitividad [BIO2011-26669, PTA2009-1865-P]
- Instituto de Salud Carlos III
The ability of small molecules to interact with multiple proteins is commonly referred to as polypharmacology. The now widely accepted polypharmacology of drugs is of particular interest for human health as it has implications beyond therapeutic efficacy, from anticipating adverse drug reactions to identifying potential repurposing opportunities. There have been a number of studies relating the extent of drug polypharmacology to the physicochemical properties and fragment composition of the drug itself, but also to the protein family and distant binding site similarities of the drug's primary target. Taken together, all these observations lead to speculate that the origins of drug polypharmacology may lie at the heart of protein evolution and that polypharmacology may just be a reminiscent signature of some of the mechanisms of adaptation that primitive biological systems developed to increase the chances of survival in a highly variable early chemical environment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据